...
首页> 外文期刊>The Journal of biological chemistry >Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport
【24h】

Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport

机译:甘氨酸二聚化基序在N-末端跨膜结构域的高密度脂蛋白受体SR-BI所需的正常受体低聚和脂质转运所需

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Scavenger receptor class B, type I (SR-BI), a CD36 superfamily member, is an oligomeric high density lipoprotein (HDL) receptor that mediates negatively cooperative HDL binding and selective lipid uptake. We identified in the N-terminal transmembrane (N-TM) domain of SR-BI a conserved glycine dimerization motif, G15X2G18X3AX2G25, of which the submotif G18X3AX2G25 significantly contributes to homodimerization and lipid uptake activity. SR-BI variants were generated by mutations (single or multiple Gly → Leu substitutions) or by replacing the N-TM domain with those from other CD36 superfamily members containing (croquemort) or lacking (lysosomal integral membrane protein (LIMP) II) this glycine motif (chimeras). None of the SR-BI variants exhibited altered surface expression (based on antibody binding) or HDL binding. However, the G15L/G18L/G25L triple mutant exhibited reductions in cell surface homo-oligomerization (>10-fold) and the rate of selective lipid uptake (~2-fold). Gly18 and Gly25 were necessary for normal lipid uptake activity of SR-BI and the SR-BI/croquemort chimera. The lipid uptake activity of the glycine motif-deficient SR-BI/LIMP II chimera was low but could be increased by introducing glycines at positions 18 and 25. The rate of lipid uptake mediated by SR-BI/LIMP II chimeras was proportional to the extent of receptor oligomerization. Thus, the glycine dimerization motif G18X3AX2G25 in the N-TM domain of SR-BI contributes substantially to the homo-oligomerization and lipid transport activity of SR-BI but does not influence the negative cooperativity of HDL binding. Oligomerization-independent binding cooperativity suggests that classic allostery is not involved and that the negative cooperativity is probably the consequence of a “lattice effect” (interligand steric interference accompanying binding to adjacent receptors).
机译:清除剂受体B类,I型(SR-BI),CD36超家族成员是寡聚高密度脂蛋白(HDL)受体,其介导负合作的HDL结合和选择性脂质摄取。我们在SR-Bi的N-末端跨膜(N-TM)结构域中鉴定在SR-BI的N-末端跨膜(N-TM)结构域,其中潜亚硫化物G18X3AX2G25的G15MX2G18X3AX2G25显着有助于同型二聚体和脂质摄取活性。 SR-BI变体由突变(单或多甘甘醇→Leu取代)产生或通过将N-TM结构域与来自含有(克鲁马口语)或缺乏(溶酶体整体膜(LIMP)II)的葡糖蛋白(溶酶体积分膜蛋白(LIMP)II)替换)主题(嵌合体)。没有一个SR-BI变体表现出改变的表面表达(基于抗体结合)或HDL结合。然而,G15L / G18L / G25L三重突变体表现出在细胞表面同源 - 低聚(> 10倍)中的减少和选择性脂摄取(〜2倍)的速率。 GLY18和GLY25对于SR-BI和SR-BI / CROQUEMOR CHIMERA的正常脂质摄取活性是必需的。甘氨酸缺陷型SR-BI / LIMP II嵌合体的脂质摄取活性低,但通过在第18次和25的位置引入甘氨酸可以增加。由SR-BI / LIMP II嵌合体介导的脂质摄取率与含量成比例受体寡聚化的程度。因此,SR-BI的N-TM结构域中的甘氨酸二聚化学MOTIF G18X3AX2G25基本上有助于SR-BI的同源寡聚和脂质传输活性,但不会影响HDL结合的负合作性。无关的邻无关的结合协作表明,不涉及经典的构象,并且负合作性可能是“晶格效应”的结果(伴随着与相邻受体的结合的中间体空间干扰)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号